112953 ⎘
Oligonucleotides characterized by their use Polymorphic or mutational markers
BIOMARKERS FOR STING AGONISTS AND METHODS OF USING THE SAME
#902NEXT GENERATION SEQUENCING AND ARTIFICIAL INTELLIGENCE-BASED APPROACHES FOR IMPROVED CANCER DIAGNOSTICS AND THERAPEUTIC TREATMENT SELECTION
#903SPATIAL MULTIOMICS USING IN SITU REVERSE TRANSCRIPTION
#904METHOD FOR CHARACTERIZING A TUMOR USING TARGETED SEQUENCING
#905METHODS OF TREATING CANCER WITH KINASE INHIBITORS
#906Analysis of nucleic acid sequences
#907METHOD FOR ASSESSING RISK OF CHRONIC KIDNEY DISEASE AND CHRONIC KIDNEY DISEASE RISK ASSESSMENT SYSTEM
#908METHOD FOR ANALYSING THE DEGREE OF SIMILARITY OF AT LEAST TWO SAMPLES USING DETERMINISTIC RESTRICTION-SITE WHOLE GENOME AMPLIFICATION ( DRS-WGA)
#909Lettuce Plants with Bremia-Resistance Providing Genomic Fragments from Lactuca Serriola
#910MOLECULAR TEST FOR MONKEYPOX VIRUS
#911PROBE SET FOR ISOTHERMAL ONE-POT REACTION FOR DETECTING STRAINS WITH BIOLOGICALLY ACTIVE BIOSYNTHETIC PATHWAY AND USES THEREOF
#912Methods For Determining Antimicrobial Drug Resistance
#913METHOD FOR DETECTING GENE MUTATION AND METHOD FOR DIFFERENTIATING SOMATIC CELL MUTATION FROM GERM CELL LINE MUTATION
#914ONCOLOGIC VARIATIONS ASSOCIATED WITH CANCER AND METHODS OF TREATMENT
#915METHODS FOR SIMULTANEOUS AMPLIFICATION OF TARGET LOCI
#916SEQUENCE ANALYSIS USING META-STABLE NUCLEIC ACID MOLECULES
#917PRETREATMENT METHOD FOR DNA ADDUCTOMICS SAMPLES
#918MAIZE GENE KRN2 AND USES THEREOF
#919TYPE I-A CRISPR-CAS3 SYSTEM FOR GENOME EDITING AND DIAGNOSTICS
#920TREATMENT AND DETECTION OF INHERITED NEUROPATHIES AND ASSOCIATED DISORDERS
#921GENETIC RESISTANCE TO VIRAL DISEASE IN SALMONID FISH
#922PLANTS COMPRISING WHEAT G-TYPE CYTOPLASMIC MALE STERILITY RESTORER GENES, MOLECULAR MARKERS AND USES THEREOF
#923NUCLEIC ACID CONSTRUCT CAPABLE OF MEASURING HOMOLOGOUS RECOMBINATION ACTIVITY AND UTILIZATION THEREOF
#924STREAMLINED PLATFORM FOR BACTERIAL IDENTIFICATION AND ANTIBIOTIC SUSCEPTIBILITY TEST
#925CANCER CLASSIFICATION AND PROGNOSIS BASED ON SILENT AND NON-SILENT MUTATIONS
#926SYSTEM AND METHOD FOR CLEANING NOISY GENETIC DATA AND DETERMINING CHROMOSOME COPY NUMBER
#927METHODS FOR NON-INVASIVE PRENATAL TESTING
#928EMBRYONIC NUCLEIC ACID ANALYSIS
#929COTTON TRANSGENIC EVENT MON 88702 AND METHODS FOR DETECTION AND USES THEREOF
#930ALBUGO CANDIDA RESISTANCE GENE
#931LASOFOXIFENE TREATMENT OF BREAST CANCER
#932COMPOSITE PRIMER SET AND KIT FOR IDENTIFYING POLYMORPHIC MARKERS OF CATTLE AND APPLICATIONS THEREOF
#933MONITORING CIRCULATING TUMOR DNA TO IMPROVE SUBCLONE PENETRATION OF FOLLOW-UP NEOANTIGEN CANCER VACCINES
#934COMPOSITIONS AND METHODS FOR DETECTING PREDISPOSITION TO CARDIOVASCULAR DISEASE
#935Providing Content on Multiple Devices
#936METHOD FOR IDENTIFYING AND DIAGNOSING GENETIC DISORDERS AND SYETEM THEREOF
#937DETECTION OF KDM1A LOSS OF ACTIVITY FOR DIAGNOSING ENDOCRINE DISORDERS
#938METHODS AND COMPOSITIONS RELATED TO TRIPLE-NEGATIVE BREAST CANCER
#939METHODS AND KITS FOR ANALYZING NUCLEOSOMES AND PLASMA PROTEINS
#940Assay for Predicting Risk of Capecitabine-Induced Toxicity in a Subject
#941Methods and Systems for Prostate Cancer Characterization and Treatment
#942METHOD FOR DETECTING CD19 EXPRESSION
#943COLORECTAL CANCER SUBTYPE IDENTIFIER
#944Methods for assessing risk of developing a viral disease using a genetic test
#945Detection and digital quantitation of multiple targets
#946DETECTING MUTATIONS AND PLOIDY IN CHROMOSOMAL SEGMENTS
#947ACCURATE MOLECULAR DECONVOLUTION OF MIXTURE SAMPLES
#948METHODS FOR ISOLATING CELL-FREE DNA
#949PLANTS WITH REDUCED LIPASE 1 ACTIVITY
#950WHEAT WITH REDUCED SUSCEPTIBILITY TO LATE-MATURITY ALPHA-AMYLASE
#951COMPOSITIONS AND METHODS FOR ASSAYING CIRCULATING MOLECULES
#952A Genotypic Assay To Subspeciate Mycobacterium Abscessus Complex Strains And Determine Macrolide Resistance
#953METHODS AND SYSTEMS FOR NONINVASIVE AND LOCALIZED BRAIN LIQUID BIOPSY USING FOCUSED ULTRASOUND
#954Methods and Materials for Using Measles Viruses
#955PHARMACOGENOMICS SCORE TO MAKE DECISIONS ON THERAPY AUGMENTATION IN AML
#956ARRAYS TARGETING DIFFERENTIALLY ACCESSIBLE CHROMATIN REGIONS USING QUANTITATIVE POLYMERASE CHAIN REACTION
#957METHODS AND MATERIALS FOR DETECTING COLORECTAL NEOPLASM
#958CONSENSUS CODING SEQUENCES OF HUMAN BREAST AND COLORECTAL CANCER
#959RESPONSE TO EGFR BLOCKADE
#960Quantum Dot-Enrichment of CRISPR-Associated (Cas) Proteins for Environmental RNA Enrichment
#961IN VITRO MODELS FOR ESTIMATING DRUG DOSAGE
#962Sorghum Plants Having a Mutant Polynucleotide Encoding the Large Subunit of Mutated Acetohydroxyacid Synthase Protein and Increased Resistance to Herbicides
#963DETECTING MUTATIONS AND PLOIDY IN CHROMOSOMAL SEGMENTS
#964METHODS OF ANALYSIS OF 17Q22 POLYMORPHISMS ASSOCIATED WITH CANCER AND USES THEREOF
#965COMPOSITIONS AND METHODS FOR FAST MULTIPLEXED SCREENING AND MONITORING OF NPM1 MUTATIONS
#966METHODS FOR DETECTING NEOPLASM IN PREGNANT WOMEN
#967METHODS FOR SELECTING MELANOMA PATIENTS FOR THERAPY AND METHODS OF REDUCING OR PREVENTING MELANOMA METASTASIS
#968METHODS FOR SIMULTANEOUS AMPLIFICATION OF TARGET LOCI
#969SE33 MUTATIONS IMPACTING GENOTYPE CONCORDANCE
#970KINASE-DEAD MUTATION: A NEW APPROACH TO ENHANCE SOYBEAN RESISTANCE TO SOYBEAN CYST NEMATODE
#971PRODUCTS AND METHODS FOR PROMOTING MYOGENESIS
#972VARIANT BASED DISEASE DIAGNOSTICS AND TRACKING
#973METHODS FOR NON-INVASIVE PRENATAL PLOIDY CALLING
#974GENE EXPRESSION ASSAY FOR MEASUREMENT OF DNA MISMATCH REPAIR DEFICIENCY
#975METHOD FOR IDENTIFYING RESPONSIVENESS TO FIBROBLAST GROWTH FACTOR RECEPTOR 1 INHIBITOR THERAPY
#976MULTIGENE ANALYSIS OF TUMOR SAMPLES
#977METHOD OF MUTATION DETECTION IN A LIQUID BIOPSY
#978System And Method For The Detection And Prevention of Leukemia And Lymphoma
#979Small Deletion Signatures
#980METHODS FOR SIMULTANEOUS AMPLIFICATION OF TARGET LOCI
#981METHODS AND COMPOSITIONS FOR PREDICTING AND/OR MONITORING CARDIOVASCULAR DISEASE AND INTERVENTIONS THEREFOR
#982DEVICES, KITS, AND METHODS FOR DETERMINING INCREASED SUSCEPTIBILITY TO AND TREATMENT AND PREVENTION OF PERIODONTITIS, ALZHEIMER’S DISEASE, AND OTHER CONDITIONS
#983MODIFICATION OF BRASSINOSTEROID RECEPTOR GENES TO IMPROVE YIELD TRAITS
#984METHODS FOR REACTIVATING GENES ON THE INACTIVE X CHROMOSOME
#985Viral Neoepitopes and Uses Thereof
#986METHOD AND COMPOSITIONS FOR THE TREATMENT AND DETECTION OF ENDOTHELIN-1 RELATED KIDNEY DISEASES
#987METHOD AND COMPOSITIONS FOR DETECTING AN ADENOMA-ADENOCARCINOMA TRANSITION IN CANCER
#988DETECTING MUTATIONS AND PLOIDY IN CHROMOSOMAL SEGMENTS
#989METHOD TO DIAGNOSE MSI CANCER
#990METHOD OF PREDICTING CANCER RECURRENCE USING PATIENT-SPECIFIC PANEL
#991METHODS FOR SIMULTANEOUS AMPLIFICATION OF TARGET LOCI
#992HIGH THROUGHPUT NEWBORN SCREENING ASSAY FOR ANGELMAN AND PRADER-WILLI SYNDROMES
#993Method for Identification of Sensitivity of a Patient to Telomerase Inhibition Therapy
#994SNP MOLECULAR MARKER COMBINATION OF BRASSICA NAPUS L. AND APPLICATION METHOD THEREOF
#995METHODS FOR DETERMINATION OF TRANSPLANT REJECTION
#996Detecting mutations and ploidy in chromosomal segments
#997USE OF FGFR MUTANT GENE PANELS IN IDENTIFYING CANCER PATIENTS THAT WILL BE RESPONSIVE TO TREATMENT WITH AN FGFR INHIBITOR
#998METHOD FOR DETERMINING THE LIKELIHOOD THAT A SUBJECT HAS OR WILL DEVELOP CANCER
#999METHOD OF IDENTIFYING FEATURE OF TEST BODY AND MICRORNA CANCER MARKER
#1000MYC-HSF1 DUAL AMPLIFICATION AS A BIOMARKER FOR CANCER TREATMENT
#1001TRACKING APOBEC MUTATIONAL SIGNATURES IN TUMOR CELLS
#1002METHODS FOR SIMULTANEOUS AMPLIFICATION OF TARGET LOCI
#1003METHOD FOR THE ISOLATION OF DOUBLE-STRAND BREAKS
#1004A METHOD FOR THE ISOLATION OF DOUBLE-STRAND BREAKS
#1005DIAGNOSIS OF ACUTE AND CHRONIC LUNG DISEASES BY QUANTIFYING SPINK1 LEVEL
#1006Selective Reduction of Allelic Variants
#1007TARGETED RARE ALLELE CRISPR ENRICHMENT
#1008Method for evaluating tea plant (+)-catechin content
#1009HERBICIDE RESISTANT CANNABIS PLANT
#1010METHODS AND COMPOSITIONS TO DIAGNOSE AND TREAT TAUOPATHIES UTILIZING TRANSCRIPT VARIANTS OF PSEN2
#1011SOLID PHASE NEGATIVE ENRICHMENT
#10124H-PYRROLO[3,2-c]PYRIDIN-4-ONE COMPOUNDS
#1013GENETIC RESISTANCE PREDICTION AGAINST ANTIMICROBIAL DRUGS IN MIRCOORGANISMS USING STRUCTUREAL CHANGES IN THE GENOME
#1014METHOD FOR DETERMINING EVOLUTIONARY PRIMITIVE ANCESTRY OF GOJI BERRY AND USE THEREOF
#1015METHOD FOR DETECTION OF SARS-CoV-2 MUTATIONS
#1016METHODS OF DETECTING MLH1 METHYLATION
#1017URINARY TRACT CANCER TREATMENT GUIDED BY MUTATIONAL LANDSCAPE
#1018A METHOD FOR ASSESSING THE POTENTIAL EFFECT OF THERAPEUTICS ON AN INDIVIDUAL
#1019GLOBAL POLYGENIC RISK ASSESSMENT FOR BREAST CANCER
#1020DIAGNOSTIC METHOD FOR CANCER EVOLUTION PREDICTION, AND USES THEREOF
#1021Methods for assessing risk of developing a viral disease using a genetic test
#1022SYSTEM AND METHOD FOR CLEANING NOISY GENETIC DATA AND DETERMINING CHROMOSOME COPY NUMBER
#1023IDENTIFICATION AND TREATMENT OF PATIENTS WITH EPILEPSY
#1024METHODS AND COMPOSITIONS FOR DETERMINING PLOIDY
#1025METHODS OF TREATING TUMOR
#1026ENRICHMENT OF CIRCULATING TUMOR DNA
#1027COMPOSITIONS AND METHODS FOR SCREENING SOLID TUMORS
#1028OVERSAMPLING IN A COMBINED TRANSPOSER FILTERBANK
#1029METHODS AND SYSTEMS FOR ALLELE TYPING
#1030KIT AND METHOD FOR DETECTING NUCLEIC ACID AND USES THEREOF
#1031METHODS FOR SPATIAL ANALYSIS USING DNA CAPTURE
#1032ANTI-ERYTHROPOIETIN ANTIBODY
#1033METHODS FOR DIAGNOSIS AND TREATMENT OF TYPE 1 DIABETES
#1034Methods Of Treating Fabry Disease In Patients Having A Mutation In The GLA Gene
#1035SYSTEMS AND METHODS FOR GENERATING, VISUALIZING AND CLASSIFYING MOLECULAR FUNCTIONAL PROFILES
#1036THERAPEUTIC AND DIAGNOSTIC METHODS FOR CANCER
#1037SIGNAL BOOST ASSAY PERFORMED IN DROPLETS
#1038USING THE FULL REPERTOIRE OF GENETIC INFORMATION FROM BACTERIAL GENOMES AND PLASMIDS FOR IMPROVED GENETIC RESISTANCE TESTS
#1039Methods for assessing risk of developing a viral disease using a genetic test
#1040SYSTEM AND METHOD FOR CLEANING NOISY GENETIC DATA AND DETERMINING CHROMOSOME COPY NUMBER
#1041METHOD FOR MODIFYING TARGET SITE IN GENOME OF EUKARYOTIC CELL, AND METHOD FOR DETECTING PRESENCE OR ABSENCE OF NUCLEIC ACID SEQUENCE TO BE DETECTED AT TARGET SITE
#1042NOVEL THERAPEUTIC PEPTIDES FOR NEURODEGENERATION
#1043METHODS OF DETECTING SPATIAL HETEROGENEITY OF A BIOLOGICAL SAMPLE
#1044SYSTEMS AND METHODS FOR MULTI-ANALYTE DETECTION OF CANCER
#1045Rare Cell Analysis Using Sample Splitting And DNA Tags
#1046DETERMINATION OF CELLULAR KINETICS AND BIODISTRIBUTION FOR CAR-T CELLS
#1047PRIMERS FOR DETECTING TRACE AMOUNT OF RARE SINGLE- NUCLEOTIDE VARIANT AND METHOD FOR SPECIFICALLY AND SENSITIVELY DETECTING TRACE AMOUNT OF RARE SINGLE-NUCLEOTIDE VARIANT BY USING SAME
#1048TARGETED NEXT-GENERATION SEQUENCING VIA ANCHORED PRIMER EXTENSION
#1049HIGHLY STABLE AND SPECIFIC MOLECULAR BEACONS ENCAPSULATED IN CATIONIC LIPOPLEX NANOPARTICLES AND APPLICATION THEREOF
#1050USE OF GENETIC AND EPIGENETIC MARKERS TO DETECT CELL DEATH
#1051Molecular genetic approach to treatment and diagnosis of alcohol and drug dependence
#1052MOLECULAR BREEDING METHODS
#1053CANCER EVOLUTION DETECTION AND DIAGNOSTIC
#1054DRAIN FLUIDS FOR DISEASE DIAGNOSIS AND MONITORING
#1055Methods of preparing a DNA fraction enriched with circulating tumor DNA
#1056ANALYTICAL METHODS FOR CELL FREE NUCLEIC ACIDS AND APPLICATIONS
#1057MATERNAL PLASMA TRANSCRIPTOME ANALYSIS BY MASSIVELY PARALLEL RNA SEQUENCING
#1058OVERSAMPLING IN A COMBINED TRANSPOSER FILTERBANK
#1059METHODS FOR PREDICTING RISK OF INTERSTITIAL PNEUMONIA
#1060METHODS FOR SIMULTANEOUS AMPLIFICATION OF TARGET LOCI
#1061CHARACTERIZATION AND TREATMENT OF ASTHMA
#1062RNA BIOMARKERS FOR HEREDITARY ANGIOEDEMA
#1063SPATIAL NUCLEIC ACID ANALYSIS
#1064ENHANCED DISEASE RESISTANCE OF MAIZE TO NORTHERN CORN LEAF BLIGHT BY A QTL ON CHROMOSOME 4
#1065IDENTIFYING PATIENT RESPONSE TO S1P RECEPTOR MODULATOR ADMINISTRATION
#1066NEOANTIGENS AS TARGETS FOR IMMUNOTHERAPY
#1067METHODS, SYSTEMS, AND COMPUTER-READABLE MEDIA FOR DETECTION OF TANDEM DUPLICATION
#1068InDel MOLECULAR MARKER OF hisD GENE OF ULTRASONICALLY-MUTAGENIZED SALMONELLA TYPHIMURIUM AND USE THEREOF
#1069MULTI-COPY REFERENCE ASSAY
#1070METHODS FOR EARLY DETECTION OF CANCER
#1071CD274 MUTATIONS FOR CANCER TREATMENT
#1072SINGLE-CELL PROFILING OF CHROMATIN OCCUPANCY AND RNA SEQUENCING
#1073PATHOGENIC GENES ASSOCIATED WITH PREMATURE OVARIAN INSUFFICIENCY AND THEIR APPLICATION
#1074METHODS FOR CHARACTERIZING LOSS OF ANTIGEN PRESENTATION
#1075IN SITU ANALYSIS OF VARIANT SEQUENCES IN BIOLOGICAL SAMPLES
#1076METHODS FOR DETECTING NUCLEIC ACID VARIANTS
#1077INFERRING MICROORGANISM OF ORIGIN FOR ANTIMICROBIAL RESISTANCE MARKERS IN TARGETED METAGENOMICS
#1078METHODS FOR PREDICTING AND TREATING CHEMORESISTANCE IN SMALL CELL LUNG CANCER PATIENTS
#1079GENOMIC STABILITY PROFILING
#1080METHODS FOR ACCURATE PARALLEL DETECTION AND QUANTIFICATION OF NUCLEIC ACIDS
#1081POOLED OPTICAL SCREENING AND TRANSCRIPTIONAL MEASUREMENTS OF CELLS COMPRISING BARCODED GENETIC PERTURBATIONS
#1082ASSESSING AND TREATING OBESITY
#1083BIOMARKERS FOR AGE-RELATED MACULAR DEGENERATION
#1084METHODS AND COMPOSITIONS FOR DETECTING SARS-COV2 VIRUS OMICRON, ALPHA, BETA, DELTA, OR GAMMA
#1085METHODS FOR IDENTIFYING CRITICALLY SHORT TELOMERES
#1086METHODS FOR DETECTING INACTIVATION OF THE HOMOLOGOUS RECOMBINATION PATHWAY (BRCA1/2) IN HUMAN TUMORS
#1087Serotonin transporter gene and treatment of opioid-related disorders
#1088NUCLEIC ACID SEQUENCING METHOD AND SYSTEM EMPLOYING ENHANCED DETECTION OF NUCLEOTIDE-SPECIFIC TERNARY COMPLEX FORMATION
#1089Treatment Of Stroke With 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Inhibitors
#1090METHODS OF TREATMENT OF CANCER PATIENTS HAVING ALTERED SETD2 BIOMARKER WITH A PD-1 ANTAGONIST
#1091TARGETED MASSIVELY PARALLEL SEQUENCING FOR SCREENING OF GENETIC HEARING LOSS AND CONGENITAL CYTOMEGALOVIRUS-ASSOCIATED HEARING LOSS
#1092ASSAYS FOR DETECTING PATHOGENS
#1093METHODS AND COMPOUNDS FOR NEOANTIGEN VACCINES
#1094Systems and methods to detect rare mutations and copy number variation
#1095MARKERS TO PREDICT MACROCYCLIC LACTONE DRUG RESISTANCE IN DIROFILARIA IMMITIS, THE CAUSATIVE AGENT OF HEARTWORM DISEASE
#1096ENHANCER OLIGONUCLEOTIDES FOR NUCLEIC ACID HYBRIDIZATION
#1097METHODS OF ADMINISTERING MONOMETHYL FUMARATE AND PRODRUGS THEREOF HAVING REDUCED SIDE EFFECTS
#1098COMPOSITIONS AND METHODS FOR DETECTING, PREVENTING, AND TREATING DISTURBED MICROBIOTA-IMMUNE HOMEOSTASIS
#1099SINGLE-NUCLEOTIDE POLYMORPHISM LOCUS SIGNIFICANTLY RELATED TO YARDLONG BEAN ANTHOCYANIN CONTENT, KOMPETITIVE ALLELE-SPECIFIC POLYMERASE CHAIN REACTION MARKERS AND APPLICATION THEREOF
#1100SEQUENCES FOR DETECTION AND IDENTIFICATION OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) OF MREJ TYPES xi to xx
#1101PREDICTING RESISTANCE TO TILAPIA LAKE VIRUS
#1102Methods for using mosaicism in nucleic acids sampled distal to their origin
#1103COMPOSITIONS COMPRISING NULLOMERS AND METHODS OF USING THE SAME FOR CANCER DETECTION AND DIAGNOSIS
#1104METHODS FOR USING A HYPOMETHYLATING AGENT TO TREAT DISEASES AND DISORDERS BASED ON GENE MUTATION PROFILES
#1105Detection of Cancer in Urine
#1106APPARATUS AND METHOD FOR EARLY CANCER DETECTION AND CANCER PROGNOSIS USING A NANOSENSOR WITH RAMAN SPECTROSCOPY
#1107FORMULATION OF PEPTIDE IMMUNOTHERAPIES
#1108COMBINATION, METHOD AND KIT FOR DETECTING NUCLEIC ACID
#1109NON-INVASIVE PRENATAL TESTING AT EARLY STAGE OF PREGNANCY
#1110METHODS FOR DETECTION OF DONOR-DERIVED CELL-FREE DNA IN TRANSPLANT RECIPIENTS OF MULTIPLE ORGANS
#1111Method for Detecting a Mutation in a Microsatellite Sequence
#1112PRODUCTION METHOD OF BIOMARKER SET FOR CANCER DETECTION
#1113BRASSICA OLERACEA PLANTS WITH IMPROVED NUTRITIONAL VALUE
#1114Methods for Treating Multiple Myeloma
#1115DNA BARCODE FOR RECOGNIZING ORIGINAL PLACE OF FLOCCULARIA LUTEOVIRENS
#1116DNA BARCODE FOR SCREENING FLOCCULARIA LUTEOVIRENS WITH HIGH TOTAL FAT CONTENT
#1117PROSTATE CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD
#1118Multiple-tiered screening and second analysis
#1119METHODS AND COMPOSITIONS RELATED TO FULL-LENGTH EXCISED INTRON RNAS (FLEXI RNAS)
#1120GENE MODIFICATION QUANTIFICATION IN SINGLE-CELL SEQUENCING
#1121METHODS FOR CLONOTYPE SCREENING
#1122MOUSE MODEL AND TREATMENT OF HEREDITARY INCLUSION BODY MYOPATHY
#1123TREATMENT OF CORNEAL VASCULARISATION
#1124Novel Y-Chromosomal Short Tandem Repeat Markers for Typing Male Individuals
#1125USE OF MUTATIONAL SIGNATURES FOR MULTIPLE CANCER TYPES
#1126METHODS AND SYSTEMS FOR ANALYZING COMPLEX GENOMIC REGIONS
#1127OLIGONUCLEOTIDES FOR TREATING EXPANDED REPEAT DISEASES
#1128SOLID PHASE NEGATIVE ENRICHMENT
#1129Methods Of Treating Fabry Disease In Patients Having A Mutation In The GLA Gene
#1130INTROGRESSION OF TOLCNDV-ES RESISTANCE CONFERRING QTLS IN CUCUMIS SATIVUS PLANTS
#1131DETECTION OF SARS-COV-2 VARIANT
#1132PRIMER SET, REAGENT COMPOSITION AND METHOD FOR THE DETECTION OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA)
#1133Methods for monitoring residual disease
#1134ANALYSIS OF EFFLUENT
#1135DIAGNOSTIC AND THERAPEUTIC METHODS FOR CANCER
#1136SINGLE-MOLECULE SEQUENCE AND HIGH SENSITIVITY METHYLATION ANALYSIS FOR TISSUE-SPECIFIC ANALYSIS
#1137COVALENT CHEMISTRY ENABLES EXTRACELLULAR VESICLE PURIFICATION ON NANOSUBSTRATES ? TOWARD EARLY DETECTION OF HEPATOCELLULAR CARCINOMA
#1138Methods of treating decreased bone mineral density with cluster of differentiation 109 (CD109) inhibitors
#1139SUBSTITUTED QUINAZOLINES FOR INHIBITING KINASE ACTIVITY
#1140CERAMIDE AND SPINGOMYELIN IN NEUROLOGICAL DISORDERS
#1141CDI Rapid Test For COVID-19 Variants of Concern
#1142MUTATION DETECTION ASSAY
#1143Methods and compositions for detecting esophageal neoplasias and/or metaplasias in the esophagus
#1144Malignant Mesothelioma Susceptibility As A Result Of Germline Leucine-Rich Repeat Kinase 2 (LRRK2) Alterations
#1145COMPOSITIONS AND METHODS FOR SIMULTANEOUS GENETIC ANALYSIS OF MULTIPLE LIBRARIES
#1146METHODS FOR DETECTION AND REDUCTION OF SAMPLE PREPARATION-INDUCED METHYLATION ARTIFACTS
#1147TISSUE-SPECIFIC METHYLATION MARKER
#1148METHODS FOR TREATING CANCERS
#1149NONSELECTIVE METABOTROPIC GLUTAMATE RECEPTOR ACTIVATORS FOR TREATMENT OF ANOREXIA NERVOSA AND BINGE EATING DISORDER
#1150METHOD FOR IDENTIFYING WHETHER A DIPLOID POTATO IS SELF-COMPATIBLE
#1151BILE ACID METABOLITES FOR DIAGNOSING AND TREATING DEPRESSIVE DISORDERS
#1152FRAGMENTOMICS IN URINE AND PLASMA
#1153Methods for early detection of cancer
#1154Methods for early detection of cancer
#1155METHOD FOR SELECTING NORMALIZING GENES FOR COPY NUMBER VARIATION DETECTION AND COMPOSITION FOR DETECTING C-MET COPY NUMBER VARIATION SELECTED BY METHOD
#1156Treatment Of Obesity In Subjects Having Variant Nucleic Acid Molecules Encoding Calcitonin Receptor (CALCR)
#1157NON-INVASIVE DETECTION OF FETAL GENETIC TRAITS
#1158METHOD FOR DETECTING ALLELES ASSOCIATED WITH KERATOCONUS
#1159DNA FRAGMENT JOINING DETECTING METHOD AND KIT THEREOF
#1160METHODS OF TREATMENT OF BREAST CANCER
#1161Methods and Systems for Analyzing Nucleic Acid Molecules
#1162METHODS AND SYSTEMS FOR PREDICTING CANCER HOMOLOGOUS RECOMBINATION PATHWAY DEFICIENCY, AND DETERMINING TREATMENT RESPONSE
#1163Methods and systems for evaluating microsatellite instability status
#1164ELITE EVENT EE-GH7 AND METHODS AND KITS FOR IDENTIFYING SUCH EVENT IN BIOLOGICAL SAMPLES
#1165LETTUCE VARIETY NUN 08261 LTL
#1166Listeria-monocytogenes detection method
#1167METHODS FOR EARLY DETECTION OF CANCER
#1168PRODUCT FOR DIAGNOSING CONGENITAL SCOLIOSIS AND APPLICATION THEREOF
#1169METHODS OF IDENTIFYING AND TREATING A PERSON HAVING A PREDISPOSITION TO OR AFFLICTED WITH A CARDIOMETABOLIC DISEASE
#1170FRET-BASED ANALYTES DETECTION AND RELATED METHODS AND SYSTEMS
#1171PHARMACEUTICAL USE OF FAM19A5 INVOLVED IN REGULATING GLIOGENESIS
#1172TREATING CANCER IN PATIENT HAVING CO-OCCURRING GENETIC ALTERATION IN FGFR2 AND A CANCER DRIVER GENE
#1173METHODS FOR TREATING NEUROBLASTOMA
#1174Methods and Processes for Non-Invasive Assessment of Genetic Variations
#1175GENETIC TESTING FOR ALIGNMENT-FREE PREDICTING RESISTANCE OF MICROORGANISMS AGAINST ANTIMICROBIAL AGENTS
#1176Methods for sequencing samples
#1177Methods for sequencing samples
#1178COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF ALT CANCER
#1179Markers of Triple-Negative Breast Cancer and Uses Thereof
#1180METHODS OF DETECTING SIGNATURES OF DISEASE OR CONDITIONS IN BODILY FLUIDS
#1181METHODS OF DETECTING CONGENITAL HEART DISEASE
#1182METHODS FOR SIMULTANEOUS AMPLIFICATION OF TARGET LOCI
#1183DUAL-PROBE METHOD FOR FLUORESCENCE QUANTITATIVE PCR
#1184EPIGENETIC ANALYSIS OF CELL THERAPY AND RELATED METHODS
#1185METHODS FOR GENOMIC IDENTIFICATION OF PHENOTYPE RISK
#1186Graphene-based malaria sensor, methods and uses thereof
#1187THERAPEUTIC STRATEGIES TO TARGET TUMORS WITH ALTERATIONS IN LKB1 PATHWAY
#1188METHODS FOR PREDICTING RESPONSIVENESS OF PROSTATE CANCER PATIENTS TO PARP INHIBITORS
#1189Methods and systems for spatial mapping of genetic variants
#1190PHASED GENOME SCALE EPIGENETIC MAPS AND METHODS FOR GENERATING MAPS
#1191SMALL AUXIN UPREGULATED (SAUR) GENE FOR THE IMPROVEMENT OF ROOT SYSTEM ARCHITECTURE, WATERLOGGING TOLERANCE, DROUGHT RESISTANCE AND YIELD IN PLANTS AND METHODS OF USES
#1192METHODS AND COMPOSITIONS FOR MUTAGENESIS SCREENING IN MAMMALIAN CELLS
#1193Treatment Of Inflammation With Glucocorticoids And Angiopoietin-Like 7 (ANGPTL7) Inhibitors
#1194Stacked herbicide tolerance event 8264.44.06.1, related transgenic soybean lines, and detection thereof
#1195TOMATO HYBRID SVTG6217 AND PARENTS THEREOF
#1196BIOMARKERS AND USES THEREOF
#1197PANEL AND METHODS FOR POLYNUCLEOTIDE DETECTION
#1198METHODS FOR DETECTING ONCOGENIC KRAS MUTATIONS
#1199DETECTION AND TREATMENT OF DISEASE EXHIBITING DISEASE CELL HETEROGENEITY AND SYSTEMS AND METHODS FOR COMMUNICATING TEST RESULTS
#1200FETAL ANEUPLOIDY DETECTION BY SEQUENCING